Lukas Kovar

Schräpel C, Kovar L, Selzer D, Hofmann U, Tran F, Reinisch W, Schwab M, Lehr T. External model performance evaluation of twelve infliximab population pharmacokinetic models in patients with inflammatory bowel disease. Pharmaceutics 2021;13(9):1368.

Kohl Y, Hesler M, Drexel R, Kovar L, Dähnhardt-Pfeiffer S, Selzer D, Wagner S, Lehr T, von Briesen H, Meier F. Influence of physicochemical characteristics and stability of gold and silver nanoparticles on biological effects and translocation across an intestinal barrier - a case study from in vitro to in silico. Nanomaterials 2021;11(6):1358.

Kovar L, Weber A, Zemlin M, Kohl Y, Bals R, Meibohm B, Selzer D, Lehr T. Physiologically-based pharmacokinetic (PBPK) modeling providing insights into fentanyl pharmacokinetics in adults and pediatric patients. Pharmaceutics 2020;12(10):908.

Kovar L, Schräpel C, Selzer D, Kohl Y, Bals R, Schwab M, Lehr T. Physiologically-based pharmacokinetic (PBPK) modeling of buprenorphine in adults, children and preterm neonates. Pharmaceutics 2020;12(6):578.

Kovar L, Selzer D, Britz H, Benowitz N, St. Helen G, Kohl Y, Bals R, Lehr T. Comprehensive parent-metabolite PBPK/PD modeling insights into nicotine replacement therapy strategies. Clin Pharmacokinet 2020;59(9):1119-1134.

Cicali EJ, Smith DM, Duong BQ, Kovar LG, Cavallari LH, Johnson JA. A scoping review of the evidence behind cytochrome P450 2D6 isoenzyme inhibitor classifications. Clin Pharmacol Ther 2020;108(1):116-125.

Kovar L, Wojtyniak JG, Schräpel C, Lehr T. Pharmakometrie erklärt: Wie verändert sie die moderne Pharmazie? PZ Prisma 2019;26:217-230.

Kovar L, Schmidt S, Derendorf H. Maßgeschneidert: Die Pharmakogenetik ebnet den Weg für erfolgreiche individualisierte Interventionen. DAZ 2018;48:3000-3004.